AUTH/3870/1/24: Complainant v AstraZeneca — Allegations about clinical trial material (Out of scope) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/3870/1/24
Parties	Complainant v AstraZeneca
Issue	Allegations about clinical trial material
Complaint received	06 January 2024
Completed	20 September 2024
Appeal	No appeal
Decision	Outwith the scope of the Code
Breaches	Not stated (no case report; outwith scope)
Sanctions	None stated
Additional sanctions	Not stated
PMCPA publication	No case summary; no case report (outwith scope)

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A complaint was made against AstraZeneca concerning allegations about clinical trial material.
The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →